The BalancedInvestor Club

EKSO Market Analysis

Overview

Fundamentals

P/E ratio—
EPS (TTM)$-5.110.0% YoY
Profit margin-91.4%HEALTHCARE
Market cap$42.0MMicro cap

Valuation

Forward P/E
—
PEG ratio
0.00
P/B
20.20
P/S (TTM)
3.28
EV/EBITDA
0.46

Profitability & growth

ROE (TTM)
-107.6%
Operating margin
-119.7%
Revenue growth YoY
-38.3%
Dividend yield
—
Beta
0.78
Last earnings
Mar 31, 2026 · Estimate $-0.23 · Reported $-2.04
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Ekso Bionics Holdings Inc

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company is headquartered in Richmond, California.

Classification

Sector
Healthcare
Industry
Medical Instruments & Supplies
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
101 GLACIER POINT, SAN RAFAEL, CA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$42.0M
Shares outstanding$3.6M
52W high$13.50
52W low$2.73

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer